Literature DB >> 2042635

Potential physiologic roles for epidermal growth factor in the kidney.

R C Harris1.   

Abstract

Epidermal growth factor (EGF) is a 53-amino acid polypeptide that is known to produce a number of biologic effects both in vitro and in vivo. High concentrations of EGF are found in urine, and high concentrations of prepro-EGF mRNA have been detected in kidney, localized to thick ascending limb of Henle (TALH) and distal convoluted tubule. Specific high-affinity EGF receptors have been demonstrated in mesangial cells, proximal tubule, and cortical and inner medullary collecting duct, as well as in medullary interstitial cells. In the proximal tubule, EGF binding and EGF receptor-associated tyrosine kinase activity are localized to basolateral membrane, and functional responses in collecting duct are observed only with basolateral administration of EGF. A number of renal responses to administration of EGF have recently been described, including modulation of glomerular hemodynamics, renal metabolism, tubular transport functions, and eicosanoid synthesis. In addition, EGF has been shown to be a potent mitogen in vitro for a variety of cell types in the kidney and may be an important mediator of renal repair following injury.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2042635     DOI: 10.1016/s0272-6386(12)80336-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  15 in total

1.  Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury.

Authors:  F Terzi; M Burtin; M Hekmati; P Federici; G Grimber; P Briand; G Friedlander
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  Induction of renal adenocarcinoma by a nonmutated erbB oncogene.

Authors:  C A Taglienti-Sian; B Banner; R J Davis; H L Robinson
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

3.  Epidermal growth factor receptor inhibition with erlotinib ameliorates anti-Thy 1.1-induced experimental glomerulonephritis.

Authors:  Jukka M Rintala; Johanna Savikko; Sini E Rintala; Niina Palin; Petri K Koskinen
Journal:  J Nephrol       Date:  2015-09-30       Impact factor: 3.902

4.  EGFR activity is required for renal tubular cell dedifferentiation and proliferation in a murine model of folic acid-induced acute kidney injury.

Authors:  Song He; Na Liu; George Bayliss; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-19

Review 5.  The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology.

Authors:  Fenghua Zeng; Amar B Singh; Raymond C Harris
Journal:  Exp Cell Res       Date:  2008-08-19       Impact factor: 3.905

Review 6.  The renal cytochrome P-450 arachidonic acid system.

Authors:  M Laniado-Schwartzman; N G Abraham
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

Review 7.  Epidermal growth factor, from gene organization to bedside.

Authors:  Fenghua Zeng; Raymond C Harris
Journal:  Semin Cell Dev Biol       Date:  2014-02-07       Impact factor: 7.727

Review 8.  EGF receptor in neoplasia and metastasis.

Authors:  K Khazaie; V Schirrmacher; R B Lichtner
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

9.  State of the human proteome in 2013 as viewed through PeptideAtlas: comparing the kidney, urine, and plasma proteomes for the biology- and disease-driven Human Proteome Project.

Authors:  Terry Farrah; Eric W Deutsch; Gilbert S Omenn; Zhi Sun; Julian D Watts; Tadashi Yamamoto; David Shteynberg; Micheleen M Harris; Robert L Moritz
Journal:  J Proteome Res       Date:  2013-12-06       Impact factor: 4.466

10.  Increased expression of EGFR and TGF-alpha in segmental renal dysplasia in duplex kidney.

Authors:  Valeria Solari; Hideki Shima; Prem Puri
Journal:  Pediatr Surg Int       Date:  2004-04-03       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.